Maximilian Moldaschl
Co-founder & CFO; ex-global macro strategist
London, England, United Kingdom
Summary
Transitioned from institutional macro/asset-allocation research to founding and financially leading start-ups in wellness and therapeutics. citywire+2
Experienced cross-asset strategist with a decade-plus track record at major financial institutions (Citi and BNP Paribas AM), focused on macro, asset allocation and multi-asset communication. citywire+1
Founder and operator of consumer-facing and R&D-focused ventures (NaturalWorks and NW PharmaTech) combining product development, scientific oversight and commercialisation. tracxn+2
Values product transparency and science-backed consumer education, pursuing lab-testing, batch-tracking and evidence-based communication in the CBD and wellness space. co+1
Work
Education
Projects
Writing
Patent application: Smoke filtration device (Publication number 20230248052)
August 1, 2023Patent application for a smoke filtration device comprising a sintered ceramic frusto-conical tubular body with an open-cell porous internal smoke-filtering passage; inventors include Maximilian Moldaschl.
Multi-Asset Spotlight (MAQS Spotlight)
January 1, 2018Multi-asset research/spotlight material co-authored while at BNP Paribas AM covering cross-asset perspectives and strategy (MAQS group commentary).